ArticleEconomic analysis and policy2022
Studying corporate liquidity and regulatory responses for economic recovery in COVID-19 crises.
Article in Economic analysis and policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Exploring sustainable healthcare: Innovations in health economics, social policy, and management.Heliyon · 2024Article
- Impact of fiscal policies and green financing on firm innovation and firm value for green economic recovery.Heliyon · 2024Article
- How Covid-19 impacts the financing in SMEs: Evidence from private firms.Economic analysis and policy · 2023Article
- The Protective Nature of Gold During Times of Oil Price Volatility: An Analysis of the COVID-19 Pandemic.The extractive industries and society · 2023Article
- Can the carbon emissions trading improve the enterprise environmental responsibility?Environmental science and pollution research international · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many enterprises across the European Union (EU) have been hampered by the massive spread of COVID-19. It has severely impacted revenues and financial flows, potentially leading to an increase in corporate insolvency. This study investigates the influence of this new coronavirus on the solvency status of businesses in EU Member States. Several stress scenarios were constructed for non-financial listed enterprises. The results reveal a gradual surge in the possibility of default, a rise in loan repayment, and coverage being refused. According to our findings, the solvency profiles of all firms are deteriorating. Industries, such as mining, mass production, and retail, are the most susceptible to a drop in sales income and market capitalization. Before COVID-19, previous research had looked at policy options for maintaining solvency. Our data imply that a tax delay is adequate if there is a slight deterioration in the economic outlook. There should be hybrid assistance through loans and equity for even a slight deterioration in the state of an economy. This research will benefit policymakers, corporate executives, and creditors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.